0
0
5/24/23 at 11:00am
Organization
Wired
Author
Grace Huckins
30 words
0
Comments
Antibody treatments clear amyloid protein from patients' brains, slowing the progression of their disease but potentially inducing deadly swelling.
You are the first to view
https://www.wired.com/story/alzheimers-drugs-benefits-risks-lecanemab-donanemab/
Create an account
or login to join the discussion